Tadalafil
- Product NDC
- 70518-2862
- 11-digit product format
- 705182862
- Labeler code
- 70518
- Product ID
- 70518-2862_d773fd82-b72d-1678-e053-2a95a90acefd
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tadalafil
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA210145
- Marketing category
- ANDA
- Marketing start
- 2020-08-26
- Marketing end
- 0000-00-00
- Substance
- TADALAFIL
- Active strength
- 20 mg/1
- Pharmacologic classes
- Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-2862-0 | 70518286200 | 12 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70518-2862-0) | 2020-08-26 | 0000-00-00 | No | No | Current |
| 70518-2862-1 | 70518286201 | 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70518-2862-1) | 2021-12-09 | 0000-00-00 | No | No | Current |